Financing Drug Research: What are the Issues?
28 Pages Posted: 21 May 2008
Abstract
Rising drug prices are placing an ever larger burden on family budgets and the economy. The Center for Medicare and Medicaid Services estimates 2004 expenditures at $207 billion (more than $700 per person), and projects that annual spending will grow to more than $500 billion by 2013 (more than $1,600 per person). The immediate cause of high drug prices is government granted patent monopolies, which allow drug companies to charge prices that are often 400 percent, or more, above competitive market prices.
Suggested Citation: Suggested Citation
Baker, Dean, Financing Drug Research: What are the Issues?. 2008 Industry Studies Conference Paper, Available at SSRN: https://ssrn.com/abstract=1134983 or http://dx.doi.org/10.2139/ssrn.1134983
Do you have negative results from your research you’d like to share?
Recommended Papers
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.